The Latest Cardiac and Vascular News
THE WOODLANDS, Texas, July 28, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the pricing of its previously announced underwritten public offering of 16,843,600 shares of its common stock, par value $0.001 (the “Common Stock”). The shares of Common Stock are being offered at a public […]
Q2 2022 reported revenue of $295.0 million, up 5.2% compared to Q2 2021 Q2 2022 constant currency revenue, organic* up 7.4% compared to Q2 2021 Q2 2022 GAAP operating margin of 7.9%, compared to 3.2% in Q2 2021 Q2 2022 non-GAAP operating margin of 19.1%, compared to 16.3% in Q2 […]
− Achieved Second Quarter 2022 Global Net Product Revenues of $214 Million for ONPATTRO®, GIVLAARI®, and OXLUMO® (33% Growth vs. Same Period Last Year) – − Received FDA Approval of AMVUTTRA™ (vutrisiran) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults – − Expects to Report Topline Results from APOLLO-B Phase 3 […]
Prairie Village, KS – July 28, 2022 –Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced that Raymond (Chip) Richter has joined the company as Vice President of Reimbursement. Richter is a healthcare executive and leader with over two […]
MARLBOROUGH, Mass., July 27, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.244 billion during the second quarter of 2022, growing 5.4 percent on a reported basis, 9.6 percent on an operational1 basis and 6.6 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income […]
SUNNYVALE, Calif., July 26, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2022. “We achieved several important milestones in the second quarter. We expanded […]
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2022 third quarter ended June 30, 2022 and updated its financial outlook for its fiscal 2022. Summary of Third Quarter and Recent […]
SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the appointment of two seasoned executives to its leadership team. Brice Bobzien will join the company as the Chief Financial Officer on August 8, 2022, […]
BOSTON, July 26, 2022 /PRNewswire/ — Elucid, a novel non-invasive software company providing physicians with AI-powered imaging to characterize cardiovascular disease, is pleased to announce that Todd C. Villines, MD, is joining the company as Chief Medical Officer. Dr. Villines will be leading clinical strategy development and execution for Elucid’s commercial and in-development […]
WEST CHESTER, Pa., July 26, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce that, international thought leader, Professor Andrew Holden has graciously agreed to join the VESTECK Scientific Advisory Board (SAB). A New Zealander, Professor Holden is currently the Director of Northern Region Interventional Radiology Service and is based at Auckland City Hospital. […]
